One of the biggest issues with CNBC is that they rarely talk about OTC stocks. I am not sure if it is company policy or they don't speculate with them unless something is proven/FDA approved etc.

I suppose it is a huge body of water to try to navigate if you include the OTC stocks along with the main markets.

NJ